Huda Suliman explains the nuances of drug discovery in ageing research
Lifespan.io (LEAF) - 23-Oct-2019Indications are less clear with anti-ageing compounds than with disease specific drugs
Previously the Live Forever Club – now more focused on campaigning for radical life extension in the UK
President at Icaria Life Sciences contract research organisation
Prior to joining Ichor, Dr. Suliman was manager of research & development at Acumen Detection, LLC., an SRC company. At Acumen, Dr. Suliman developed novel assay technologies for the identification of mastitis causing pathogens as part of a point of need testing system designed for dairy farms. These assay technologies, as part of the system, are patent pending.
Visit website: https://www.leafscience.org/dr-huda-suliman/
See alsoDetails last updated 15-Nov-2019
Indications are less clear with anti-ageing compounds than with disease specific drugs